REBECCA PHILLIPS: Open Payments
NPI 1366778144 · MURPHY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$409 in 14 payments from 8 companies in 2025. Trend: 2023 $403 · 2024 $230 · 2025 $409
Food & beverage: $409
| Company | Payments | Amount |
|---|---|---|
| Celltrion USA Inc. | 1 | $137 |
| AstraZeneca Pharmaceuticals LP | 5 | $108 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| Lilly USA, LLC | 2 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $29 |
| Exact Sciences Corporation | 1 | $22 |
| Novo Nordisk Inc | 1 | $19 |
| Tandem Diabetes Care, Inc. | 1 | $19 |
Products named: ZYMFENTRA, NEXIUM, TRELEGY ELLIPTA, AIRSUPRA, MOUNJARO, CAPLYTA, BREZTRI, Cologuard Collection Kit.
Industry payments across NC — which companies pay providers there.
